Uric Acid: Where Are We?

被引：2
作者：
Rosendorff, Clive [1 ,2 ]
Jogendra, Mather R. D. [1 ,2 ]
机构：
[1] James J Peters VA Med Ctr, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Med Cardiol, New York, NY USA
来源：
JOURNAL OF CLINICAL HYPERTENSION | 2013年 / 15卷 / 01期
关键词：
CHRONIC HEART-FAILURE; XANTHINE-OXIDASE INHIBITION; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; RENAL-DISEASE; RISK-FACTOR; ALLOPURINOL; MORTALITY; HYPERURICEMIA; HYPERTENSION;
D O I：
10.1111/jch.12034
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 24 条
  • [1] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
    Anker, SD
    Doehner, W
    Rauchhaus, M
    Sharma, R
    Francis, D
    Knosalla, C
    Davos, CH
    Cicoira, M
    Shamim, W
    Kemp, M
    Segal, R
    Osterziel, KJ
    Leyva, F
    Hetzer, R
    Ponikowski, P
    Coats, AJS
    [J]. CIRCULATION, 2003, 107 (15) : 1991 - 1997
  • [2] HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    BRAND, FN
    MCGEE, DL
    KANNEL, WB
    STOKES, J
    CASTELLI, WP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) : 11 - 18
  • [3] Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
    Butler, R
    Morris, AD
    Belch, JJF
    Hill, A
    Struthers, AD
    [J]. HYPERTENSION, 2000, 35 (03) : 746 - 751
  • [4] Independent impact of gout on mortality and risk for coronary heart disease
    Choi, Hyon K.
    Curhan, Gary
    [J]. CIRCULATION, 2007, 116 (08) : 894 - 900
  • [5] Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
    Doehner, W
    Anker, SD
    [J]. HEART, 2005, 91 (06) : 707 - 709
  • [6] Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies
    Doehner, W
    Schoene, N
    Rauchhaus, M
    Leyva-Leon, F
    Pavitt, DV
    Reaveley, DA
    Schuler, G
    Coats, AJS
    Anker, SD
    Hambrecht, R
    [J]. CIRCULATION, 2002, 105 (22) : 2619 - 2624
  • [7] Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options
    Doehner, Wolfram
    Landmesser, Ulf
    [J]. SEMINARS IN NEPHROLOGY, 2011, 31 (05) : 433 - 440
  • [8] Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992
    Fang, J
    Alderman, MH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18): : 2404 - 2410
  • [9] Allopurinol improves endothelial dysfunction in chronic heart failure
    Farquharson, CA
    Butler, R
    Hill, A
    Belch, JJF
    Struthers, AD
    [J]. CIRCULATION, 2002, 106 (02) : 221 - 226
  • [10] RELATION OF SERUM URIC-ACID TO MORTALITY AND ISCHEMIC-HEART-DISEASE - THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY
    FREEDMAN, DS
    WILLIAMSON, DF
    GUNTER, EW
    BYERS, T
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) : 637 - 644
123